{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T13:36:00Z","timestamp":1785245760006,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["2024.00812"],"award-info":[{"award-number":["2024.00812"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UID\/00100\/2023"],"award-info":[{"award-number":["UID\/00100\/2023"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.forsciint.2025.112713","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:19:36Z","timestamp":1762463976000},"page":"112713","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development and validation of a simple and fast method for routine analysis of new synthetic opioids and hallucinogens in whole blood using protein precipitation and UHPLC-MS\/MS"],"prefix":"10.1016","volume":"378","author":[{"given":"Joana R.P.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Antunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9879-1565","authenticated-orcid":false,"given":"Nuno R.","family":"Neng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Mustra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2025.112713_bib1","unstructured":"United Nations Office on Drugs and Crime (UNODC), World Drug Report 2024, Vienna, 2024. \u3008https:\/\/www.unodc.org\/unodc\/en\/data-and-analysis\/world-drug-report-2024.html\u3009 (accessed July 3, 2024)."},{"key":"10.1016\/j.forsciint.2025.112713_bib2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), European Drug Report 2024: Trends and Developments, Lisbon, 2024. \u3008https:\/\/www.euda.europa.eu\/publications\/european-drug-report\/2024_en\u3009 (accessed July 3, 2024)."},{"key":"10.1016\/j.forsciint.2025.112713_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2023.111775","article-title":"Non-fentanyl new synthetic opioids \u2013 An update","volume":"349","author":"Zawilska","year":"2023","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.forsciint.2025.112713_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28795","article-title":"Fentanyl and its derivatives: Pain-killers or man-killers?","volume":"10","author":"Patocka","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.forsciint.2025.112713_bib5","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s00204-024-03735-0","article-title":"Human metabolism of four synthetic benzimidazole opioids: isotonitazene, metonitazene, etodesnitazene, and metodesnitazene","volume":"98","author":"Taoussi","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112713_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PAF.0000000000000787","article-title":"Proliferation of Novel Synthetic Opioids in Postmortem Investigations After Core-Structure Scheduling for Fentanyl-Related Substances","volume":"43","author":"Papsun","year":"2022","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.forsciint.2025.112713_bib7","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Europol, EU Drug Market: New psychoactive substances \u2014 In-depth analysis, Lisboa, 2024. \u3008https:\/\/www.euda.europa.eu\/publications\/eu-drug-markets\/new-psychoactive-substances_en\u3009 (accessed July 20, 2024)."},{"key":"10.1016\/j.forsciint.2025.112713_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/jat\/bkab117","article-title":"A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS)","volume":"46","author":"Walton","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112713_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.legalmed.2023.102216","article-title":"Postmortem examination and toxicological analysis for acute metonitazene intoxication in Japan: A case report","volume":"61","author":"Morioka","year":"2023","journal-title":"Leg. Med"},{"key":"10.1016\/j.forsciint.2025.112713_bib10","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1093\/jat\/bkac062","article-title":"Intoxications in an Australian Emergency Department Involving \u2018Nitazene\u2019 Benzylbenzimidazole Synthetic Opioids (Etodesnitazene, Butonitazene and Protonitazene)","volume":"47","author":"Schumann","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112713_bib11","article-title":"Detection of two potent synthetic opioids carfentanil and 3-methylfentanyl in forensic investigations during a four-year period 2017-2020","volume":"1","author":"Noble","year":"2021","journal-title":"Emerg. Trends Drugs Addict. Health"},{"key":"10.1016\/j.forsciint.2025.112713_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110715","article-title":"Carfentanil \u2013 from an animal anesthetic to a deadly illicit drug","volume":"320","author":"Zawilska","year":"2021","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.forsciint.2025.112713_bib13","unstructured":"European Union Drugs Agency (EUDA), Fentanyl drug profile, (n.d.). \u3008https:\/\/www.euda.europa.eu\/publications\/drug-profiles\/fentanyl_en\u3009 (accessed July 22, 2024)."},{"key":"10.1016\/j.forsciint.2025.112713_bib14","first-page":"464","article-title":"A Brief Historical Overview of Psychedelic Research","volume":"9","author":"Geyer","year":"2024","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.forsciint.2025.112713_bib15","doi-asserted-by":"crossref","DOI":"10.1111\/add.16518","article-title":"A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia","author":"Darke","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.forsciint.2025.112713_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109294","article-title":"Mescaline: The forgotten psychedelic","volume":"222","author":"Vamvakopoulou","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.forsciint.2025.112713_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00414-012-0796-1","article-title":"Determination of psilocin, bufotenine, LSD and its metabolites in serum, plasma and urine by SPE-LC-MS\/MS","volume":"127","author":"Martin","year":"2013","journal-title":"Int J. Leg. Med"},{"key":"10.1016\/j.forsciint.2025.112713_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/separations8110221","article-title":"Development of a New LC-MS\/MS Screening Method for Detection of 120 NPS and 43 Drugs in Blood","volume":"8","author":"Vaiano","year":"2021","journal-title":"Separations"},{"key":"10.1016\/j.forsciint.2025.112713_bib19","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/1556-4029.15282","article-title":"Review of analytical methods for screening and quantification of fentanyl analogs and novel synthetic opioids in biological specimens","volume":"68","author":"Palmquist","year":"2023","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.forsciint.2025.112713_bib20","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/20961790.2019.1588933","article-title":"Novel synthetic opioids\u2013toxicological aspects and analysis","volume":"4","author":"Tabarra","year":"2019","journal-title":"Forensic Sci. Res"},{"key":"10.1016\/j.forsciint.2025.112713_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/separations10090502","article-title":"Determination of Lysergic Acid Diethylamide and 2-Oxo-3-Hydroxy-LSD in Blood: Validation and Comparison of Two Liquid Chromatography\u2013Tandem Mass Spectrometry Methods","volume":"10","author":"Dimitrova","year":"2023","journal-title":"Separations"},{"key":"10.1016\/j.forsciint.2025.112713_bib22","unstructured":"World Anti-Doping Agency (WADA), Minimum Criteria for Chromatographic-Mass Spectrometric Confirmation of the Identity of Analytes for Doping Control Purposes,TD2023IDCR, 2023. \u3008https:\/\/www.wada-ama.org\/sites\/default\/files\/2023-02\/td2023idcrv1.1_eng_final.pdf\u3009 (accessed February 19, 2024)."},{"key":"10.1016\/j.forsciint.2025.112713_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116176","article-title":"Development and validation of a multi-substance method for routine analysis of pesticides in post-mortem samples by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry","volume":"245","author":"Matos","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2025.112713_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2024.112174","article-title":"Detection and quantification of selected cannabinoids in oral fluid samples by protein precipitation and LC-MS\/MS","volume":"363","author":"Antunes","year":"2024","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.forsciint.2025.112713_bib25","unstructured":"AAFS Standards Board, ANSI\/ASB Standard 036 \u2013 Standard Practices for Method Validation in Forensic Toxicology, 2019. \u3008https:\/\/www.aafs.org\/sites\/default\/files\/media\/documents\/036_Std_e1.pdf\u3009 (accessed February 19, 2024)."},{"key":"10.1016\/j.forsciint.2025.112713_bib26","series-title":"Principles of Forensic Toxicology","first-page":"109","article-title":"Specimen Preparation\/Extraction","author":"Ferslew","year":"2020"},{"key":"10.1016\/j.forsciint.2025.112713_bib27","series-title":"Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters","first-page":"39","article-title":"Recent advances in mass spectrometric and other analytical techniques for the identification of drug metabolites","author":"Castro-Perez","year":"2020"},{"key":"10.1016\/j.forsciint.2025.112713_bib28","series-title":"Design of Experiments for Pharmaceutical Product Development","year":"2021"},{"key":"10.1016\/j.forsciint.2025.112713_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2019.104323","article-title":"Optimization of liquid chromatographic separation of pharmaceuticals within green analytical chemistry framework","volume":"152","author":"Dogan","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.forsciint.2025.112713_bib30","series-title":"Design of Experiments for Pharmaceutical Product Development","first-page":"43","article-title":"Full Factorial and Fractional Factorial Design Applications in Pharmaceutical Product Development","author":"Beg","year":"2021"},{"key":"10.1016\/j.forsciint.2025.112713_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.forc.2024.100554","article-title":"Use of statistical design of experiments (DoE) in Forensic Analysis: A tailored review","volume":"37","author":"Luiz Caleffo Piva Big\u00e3o","year":"2024","journal-title":"Forensic Chem."},{"key":"10.1016\/j.forsciint.2025.112713_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124059","article-title":"A quantitative LC-MS\/MS analysis of Xylazine, p-Fluorofentanyl, Fentanyl and Fentanyl-Related compounds in postmortem blood","volume":"1237","author":"Truver","year":"2024","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2025.112713_bib33","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/jat\/bkad071","article-title":"High-Throughput quantification of emerging \u201cnitazene\u201d benzimidazole opioid analogs by microextraction and UHPLC-MS-MS","volume":"47","author":"Sch\u00fcller","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112713_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1093\/jat\/bkad062","article-title":"Validation of an analytical method for quantitation of metonitazene and isotonitazene in plasma, blood, urine, liver and brain and application to authentic postmortem casework in New York City","volume":"47","author":"Pardi","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112713_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/jat\/bkaa032","article-title":"A UHPLC-MS-MS Method for the Determination of 84 Drugs of Abuse and Pharmaceuticals in Blood","volume":"45","author":"Orfanidis","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112713_bib36","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1002\/dta.3115","article-title":"Metonitazene in the United States\u2014Forensic toxicology assessment of a potent new synthetic opioid using liquid chromatography mass spectrometry","volume":"13","author":"Krotulski","year":"2021","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2025.112713_bib37","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/dta.3170","article-title":"Development and validation of a rapid LC-MS\/MS method for the detection of 182 novel psychoactive substances in whole blood","volume":"14","author":"Giorgetti","year":"2022","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.forsciint.2025.112713_bib38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/jat.3962","article-title":"Screening procedure for 38 fentanyl analogues and five other new opioids in whole blood by liquid chromatography-tandem mass spectrometry","volume":"40","author":"Adamowicz","year":"2020","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.forsciint.2025.112713_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinms.2020.10.003","article-title":"Analysis of 17 fentanyls in plasma and blood by UPLC-MS\/MS with interpretation of findings in surgical and postmortem casework","volume":"18","author":"Danaceau","year":"2020","journal-title":"Clin. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2025.112713_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jchromb.2019.05.025","article-title":"Application of a validated UHPLC-MS\/MS method for 28 fentanyl-analogue and novel synthetic opioids in whole blood in authentic forensic cases","volume":"1124","author":"Qin","year":"2019","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2025.112713_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1570-0232(02)00244-1","article-title":"Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods","volume":"774","author":"Almeida","year":"2002","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.forsciint.2025.112713_bib42","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE - Analytical GREEnness Metric Approach and Software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.forsciint.2025.112713_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2022.116553","article-title":"AGREEprep \u2013 Analytical greenness metric for sample preparation","volume":"149","author":"Wojnowski","year":"2022","journal-title":"Trends Anal. Chem."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825003573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073825003573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T10:17:51Z","timestamp":1773310671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073825003573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":43,"alternative-id":["S0379073825003573"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112713","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a simple and fast method for routine analysis of new synthetic opioids and hallucinogens in whole blood using protein precipitation and UHPLC-MS\/MS","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2025.112713","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112713"}}